|
"lee s s j"的相關文件
顯示項目 1-10 / 46 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2023 |
Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan
|
Wu, H.-Y.;Chang, P.-H.;Huang, Y.-S.;Tsai, C.-S.;Chen, K.-Y.;Lin, I.-F.;Hsih, W.-H.;Tsai, W.-L.;Chen, J.-A.;Yang, T.-L.;Lee, C.-Y.;Ho, T.-S.;Wang, H.-W.;Huang, S.-F.;Wu, A.Y.-J.;Chen, H.-J.;Chen, Y.-C.;Chen, W.-C.;Tseng, C.-H.;Lin, P.-C.;Yang, C.-H.;Hong, P.-L.;Lee, S.S.-J.;Chen, Y.-S.;Liu, Y.-C.;Wang, F.-D.;Chan, Y.-J.;Chang, F.-Y.;Chang, H.-T.;Chen, Y.-C.;Chen, Y.-H.;Cheng, M.-F.;Chi, H.;Chiu, Chiu C.-H.;Ho, M.-W.;Hsieh, S.-M.;Hsueh, P.-R.;Huang, C.-H.;Hung, C.-C.;Hwang, K.-P.;Kao, Kao K.-C.;Ko, W.-C.;Kuo, C.-F.;Lai, C.-H.;Lee, N.-Y.;Lee, S.-J.;Lin, H.-H.;Lin, Y.-T.;Liu, C.-C.;Liu, P.-Y.;Lu, P.-L.;Lu, C.-Y.;Sheng, W.-H.;Tang, H.-J.;Tsai, H.-C.;Wu, T.-S.;Yang, C.-J. |
| 國立成功大學 |
2023 |
Prediction of incidence of neurological disorders in HIV-infected persons in Taiwan: a nested case–control study
|
Weng, Y.-W.;Lee, S.S.-J.;Tsai, H.-C.;Hsu, C.-H.;Lin, S.-H. |
| 國立成功大學 |
2023 |
Geographic distribution of the major clone of extended-spectrum beta-lactamase-producing Escherichia coli infection in a pediatric community in southern Taiwan
|
Chen, W.-L.;Cheng, M.-F.;Tseng, F.-C.;Wu, P.-C.;Huang, I.-F.;Chen, Y.-W.;Chiou, Y.-H.;Chen, Y.-S.;Lee, S.S.-J.;Hung, W.-Y.;Wang, J.-L.;Hung, C.-H. |
| 臺大學術典藏 |
2022-09-07T06:39:09Z |
CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
|
Wang P.-H.; Lin S.-Y.; Lee S.S.-J.; SHU-WEN LIN; Lee C.-Y.; Wei Y.-F.; Shu C.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2022-06-27T06:59:56Z |
Recommendations and guidelines for the treatment of pneumonia in Taiwan
|
Chou C.-C.; Shen C.-F.; Chen S.-J.; Chen H.-M.; Wang Y.-C.; Chang W.-S.; Chang Y.-T.; Chen W.-Y.; Huang C.-Y.; Kuo C.-C.; Li M.-C.; Lin J.-F.; Lin S.-P.; Ting S.-W.; Weng T.-C.; Wu P.-S.; Wu U.-I.; Lin P.-C.; Lee S.S.-J.; Chen Y.-S.; Liu Y.-C.; Chuang Y.-C.; CHONG-JEN YU; Huang L.-M.; Lin M.-C.; Infectious Diseases Society of Taiwan; , Taiwan Society of Pulmonary; Critical Care Medicine,, Medical Foundation in Memory of Dr. Deh-Lin Cheng; , Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research; Education; , CY Lee's Research Foundation for Pediatric Infectious Diseases; Vaccines,, The 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group |
| 臺大學術典藏 |
2022-06-27T06:59:39Z |
CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
|
Wang P.-H.; Lin S.-Y.; Lee S.S.-J.; Lin S.-W.; Lee C.-Y.; Wei Y.-F.; Shu C.-C.; Wang J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-05-03T03:02:15Z |
Plasma Concentrations of sTREM-1 as Markers for Systemic Adverse Reactions in Subjects Treated With Weekly Rifapentine and Isoniazid for Latent Tuberculosis Infection
|
Wang T.-Y.; Feng J.-Y.; Shu C.-C.; Lee S.S.-J.; CHUNG-YU CHEN; Wei Y.-F.; Lin C.-B.; Huang W.-C.; Su W.-J.; Lin S.-M. |
| 臺大學術典藏 |
2022-01-07T06:05:47Z |
CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis
|
Wang P.-H.; Lin S.-Y.; Lee S.S.-J.; Lin S.-W.; CHIH-YUAN LEE; Wei Y.-F.; Shu C.-C.; Wang J.-Y.; Yu C.-J. |
| 國立成功大學 |
2022 |
Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms
|
Sy, C.L.;Chen, P.-Y.;Cheng, Cheng C.-W.;Huang, L.-J.;Wang, C.-H.;Chang, T.-H.;Chang, Y.-C.;Chang, Chang C.-J.;Hii, I.-M.;Hsu, Y.-L.;Hu, Y.-L.;Hung, P.-L.;Kuo, C.-Y.;Lin, P.-C.;Liu, P.-Y.;Lo, C.-L.;Lo, S.-H.;Ting, P.-J.;Tseng, C.-F.;Wang, H.-W.;Yang, C.-H.;Lee, S.S.-J.;Chen, Y.-S.;Liu, Y.-C.;Wang, F.-D. |
| 國立成功大學 |
2022 |
COVID-19-associated candidiasis and the emerging concern of Candida auris infections
|
Tsai, C.-S.;Lee, S.S.-J.;Chen, W.-C.;Tseng, C.-H.;Lee, N.-Y.;Chen, P.-L.;Li, M.-C.;Syue, L.-S.;Lo, C.-L.;Ko, W.-C.;Hung, Y.-P. |
顯示項目 1-10 / 46 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
